| Completed | Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence. Gout | Phase 1 | 2017-08-14 |
| Completed | Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence Healthy | Phase 1 | 2016-08-30 |
| Completed | RDEA3170 PK/PD Study Gout | Phase 1 | 2015-11-01 |
| Completed | Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability Healthy | Phase 1 | 2015-10-01 |
| Completed | Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects Gout | Phase 2 | 2015-07-28 |
| Completed | RDEA3170 Tablet and Capsule Bioavailability Study Healthy | Phase 1 | 2015-05-01 |
| Completed | IVIVR Assessing PK Parameters Used to Establish Bioequivalence Healthy | Phase 1 | 2015-04-01 |
| Completed | DECT Study in Allopurinol-Treated Gout Patients Gout | — | 2015-04-01 |
| Completed | RDEA3170 and Allopurinol Combination Study in Gout Subjects Gout | Phase 1 | 2014-11-01 |
| Completed | RDEA3170 Bioavailability Study Gout | Phase 1 | 2014-11-01 |
| Completed | RDEA3170 and Febuxostat Combination Study in Gout Subjects Gout | Phase 2 | 2014-10-01 |
| Completed | Mild, Moderate and Severe Renal Impairment Study Gout | Phase 1 | 2014-08-01 |
| Completed | Lesinurad Tablet Bioequivalence Healthy | Phase 1 | 2014-04-01 |
| Completed | Bioavailability of Lesinurad and Intravenous [14C]Lesinurad Healthy | Phase 1 | 2014-01-01 |
| Completed | Lesinurad Tablet Relative Bioavailability Healthy | Phase 1 | 2013-11-01 |
| Completed | Antacid Interaction Study Healthy | Phase 1 | 2013-11-01 |
| Completed | Metformin and Furosemide Drug-Drug Interaction Study Healthy | Phase 1 | 2013-10-01 |
| Completed | RDEA3170 AME Study Healthy | Phase 1 | 2013-08-01 |
| Completed | RDEA3170 Monotherapy in Subjects With Gout Gout | Phase 2 | 2013-08-01 |
| Completed | Lesinurad Interaction Study With Ranitidine Healthy | Phase 1 | 2013-07-01 |
| Completed | Single and Multiple Dose Study in Japanese Subjects Gout | Phase 1 | 2013-06-01 |
| Completed | NSAID Drug Interaction Study Gout | Phase 1 | 2013-06-01 |
| Completed | RDEA3170 and Febuxostat Drug Interaction Study Healthy | Phase 1 | 2013-06-01 |
| Completed | Lesinurad and Febuxostat Combination Extension Study in Gout Gout | Phase 3 | 2013-03-01 |
| Completed | Lesinurad and Allopurinol Combination Extension Study in Gout Gout | Phase 3 | 2013-02-01 |
| Completed | Single and Multiple Dose Study in Japanese Gout | Phase 1 | 2012-12-01 |
| Completed | Open-Label Lesinurad Monotherapy Extension Study in Gout Gout | Phase 3 | 2012-08-01 |
| Completed | Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat Tophaceous Gout | Phase 3 | 2012-01-01 |
| Completed | Combining Lesinurad With Allopurinol in Inadequate Responders Gout | Phase 3 | 2012-01-01 |
| Completed | Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors Gout | Phase 3 | 2012-01-01 |
| Completed | Combining Lesinurad With Allopurinol in Inadequate Responders Gout | Phase 3 | 2011-12-01 |
| Completed | Allopurinol Outcome Study Gout | Phase 4 | 2011-07-01 |
| Completed | Allopurinol Combination Study Gout | Phase 2 | 2009-10-01 |
| Completed | Gout Dose Response Study Hyperuricemia | Phase 2 | 2009-07-01 |
| Completed | A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout Hyperuricemia | Phase 2 | 2008-07-01 |
| Completed | Naïve HIV POC Monotherapy Trial HIV Infections | Phase 2 | 2008-01-01 |